4.59
price down icon21.54%   -1.26
pre-market  Vorhandelsmarkt:  4.59  
loading

Artelo Biosciences Inc Aktie (ARTL) Neueste Nachrichten

pulisher
Sep 30, 2025

Is Artelo Biosciences Inc. stock a top momentum playWeekly Earnings Recap & Weekly Breakout Opportunity Watchlist - newser.com

Sep 30, 2025
pulisher
Sep 30, 2025

Artelo Biosciences Announces Pricing of $2.0 Million Public Offering - GlobeNewswire

Sep 30, 2025
pulisher
Sep 30, 2025

Artelo Biosciences prices $2 million public offering of common stock By Investing.com - Investing.com Australia

Sep 30, 2025
pulisher
Sep 30, 2025

$2 Million Capital Raise: Artelo Biosciences Prices Public Offering for Cancer Drug Development - Stock Titan

Sep 30, 2025
pulisher
Sep 30, 2025

Form 424B5 ARTELO BIOSCIENCES, INC. - StreetInsider

Sep 30, 2025
pulisher
Sep 30, 2025

Candlestick signals on Artelo Biosciences Inc. stock todayWeekly Profit Summary & Daily Volume Surge Trade Alerts - newser.com

Sep 30, 2025
pulisher
Sep 30, 2025

Why Wolfspeed Shares Are Trading Higher By Over 50%; Here Are 20 Stocks Moving Premarket - Benzinga

Sep 30, 2025
pulisher
Sep 30, 2025

Is Artelo Biosciences Inc. stock a defensive play in 20252025 Momentum Check & Consistent Profit Trading Strategies - newser.com

Sep 30, 2025
pulisher
Sep 30, 2025

How Artelo Biosciences Inc. stock performs during Fed tightening cyclesQuarterly Trade Report & Community Verified Swing Trade Signals - newser.com

Sep 30, 2025
pulisher
Sep 30, 2025

When is the best time to exit Artelo Biosciences Inc.Day Trade & Community Consensus Trade Alerts - newser.com

Sep 30, 2025
pulisher
Sep 29, 2025

Artelo Biosciences launches underwritten public offering of stock - Investing.com India

Sep 29, 2025
pulisher
Sep 29, 2025

Artelo Biosciences, Inc. Announces Underwritten Public Offering of Common Stock and Pre-Funded Warrants - Quiver Quantitative

Sep 29, 2025
pulisher
Sep 29, 2025

Artelo Biosciences Announces Proposed Underwritten Public Offering - GlobeNewswire

Sep 29, 2025
pulisher
Sep 29, 2025

Nasdaq-Listed Biotech Artelo Biosciences Announces New Public Stock Offering for Cancer Research - Stock Titan

Sep 29, 2025
pulisher
Sep 29, 2025

Can Artelo Biosciences Inc. stock surprise with earnings upsideWeekly Investment Summary & AI Powered Trade Plan Recommendations - newser.com

Sep 29, 2025
pulisher
Sep 29, 2025

Statistical indicators supporting Artelo Biosciences Inc.’s strengthJuly 2025 Market Mood & Weekly Breakout Stock Alerts - newser.com

Sep 29, 2025
pulisher
Sep 29, 2025

How to track smart money flows in Artelo Biosciences Inc.Weekly Profit Report & Fast Exit and Entry Strategy Plans - newser.com

Sep 29, 2025
pulisher
Sep 29, 2025

Artelo Biosciences (ARTL) Shares Promising Interim Data from Pha - GuruFocus

Sep 29, 2025
pulisher
Sep 29, 2025

Artelo Biosciences Announces Presentation of Positive - GlobeNewswire

Sep 29, 2025
pulisher
Sep 29, 2025

Artelo Biosciences Announces Presentation of Positive Interim Phase 2 CAReS Data on ART27.13 at the 2025 Cancer Cachexia Society Conference - MarketScreener

Sep 29, 2025
pulisher
Sep 29, 2025

6% Weight Gain: Artelo's Cancer Cachexia Drug Shows Promising Results in Phase 2 Trial with Activity Boost - Stock Titan

Sep 29, 2025
pulisher
Sep 27, 2025

Visual trend scoring systems applied to Artelo Biosciences Inc.Gold Moves & Free AI Powered Buy and Sell Recommendations - newser.com

Sep 27, 2025
pulisher
Sep 27, 2025

Is Artelo Biosciences Inc. stock a safe haven assetEarnings Risk Summary & Growth Focused Stock Reports - newser.com

Sep 27, 2025
pulisher
Sep 22, 2025

How to integrate Artelo Biosciences Inc. into portfolio analysis toolsTrade Performance Summary & Low Drawdown Investment Ideas - newser.com

Sep 22, 2025
pulisher
Sep 21, 2025

Aug PreEarnings: What is Artelo Biosciences Incs TAM Total Addressable MarketQuarterly Profit Review & Verified Short-Term Plans - خودرو بانک

Sep 21, 2025
pulisher
Sep 20, 2025

Can Artelo Biosciences Inc. continue delivering strong returnsPortfolio Risk Report & Verified High Yield Trade Plans - خودرو بانک

Sep 20, 2025
$20.66
price down icon 2.36%
$84.81
price up icon 1.10%
$30.67
price up icon 4.57%
$98.62
price up icon 0.53%
$144.01
price up icon 1.67%
biotechnology ONC
$340.70
price up icon 2.36%
Kapitalisierung:     |  Volumen (24h):